Automated cell manufacturing company Mytos has partnered with Aspen Neuroscience to automate the production of customized cells for Aspen’s Parkinson’s disease therapy. Under the agreement, Aspen will use Mytos’s iDEM technology to manage cell production in its California-based factory. The deal allows Aspen to streamline its cell production process, reducing labor and enabling multibatch handling to increase capacity. A manual iDEM alternative can be learned by a single operator.
Mandiant reveals details of major Ivanti VPN vulnerability
Cybersecurity firm Mandiant has discovered a zero-day vulnerability in Ivanti Connect Secure VPN appliances being exploited by a potential China-linked cyber-espionage group. With no clear
